Ginkgo biloba for prevention of acute mountain sickness: Does it work?

High Altitude Medicine and Biology

Volumn 10, Issue 1, 2009, Pages 33-43

  Van Patot, Martha C Tissot ^a,b   Keyes, Linda E ^b   Leadbetter III, Guy ^c   Hackett, Peter H ^b,d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c and Mass Communication   (United States)

^d Institute for Altitude Medicine   (United States)

Author keywords

Acute mountain sickness; Gingko biloba; Herbal medicine; Hypoxia; Oxidative stress

Indexed keywords

AMENTOFLAVONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FLAVONE; GINKGO BILOBA EXTRACT; GINKGOLIDE; GINKGOLIDE A; GINKGOLIDE B; GINKGOLIDE C; GINKGOLIDE J; GLYCOSIDE; MEMFIT; QUERCETIN DERIVATIVE; RUTOSIDE; TERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ALTITUDE; ALTITUDE DISEASE; ALZHEIMER DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE EXACERBATION; DOSAGE SCHEDULE COMPARISON; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EXERCISE INTENSITY; GINKGO BILOBA; HUMAN; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; STANDARDIZATION; UNSPECIFIED SIDE EFFECT;

ALTITUDE; ALTITUDE SICKNESS; BIOLOGICAL AVAILABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERCISE; GINKGO BILOBA; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; RESEARCH DESIGN;

EID: 62449237043     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2008.1085     Document Type: Review

References (32)

1. Bartsch P., Bailey D.M., Berger M.M., Knauth M., and Baumgartner R.W. (2004). Acute mountain sickness: controversies and advances. High Alt. Med. Biol. 5:110-124.
2. Berg J.T. (2004). Ginkgo biloba extract prevents high altitude pulmonary edema in rats. High Alt. Med. Biol. 5:429-434.
3. Betz J., and Costello R. (2006). Studies on natural products. Arch. Internal Med. 166:370-371; author reply, 371.
4. Birks J., and Grimley Evans J. (2007). Ginkgo biloba for cognitive impairment and dementia. [update of Cochrane Database Syst. Rev. 2002 (4):CD003120; PMID: 12519586]. Cochrane Database Syst. Rev. (2):CD003120.
5. Blair J. (2007). Ginkgo SRMs: Tools for Product Analysis/Quality. NIST Tech Beat, National Institutes of Standards and Technology. August 16, 2007: http://www.nist.gov/public-affairs/ techbeat/tb2007-0816.htm#ginkgo.
6. Chow T., Browne V., Heileson H.L., Wallace D., Anholm J., and Green S.M. (2005). Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Arch. Internal Med. 165:296-301.
7. Defeudis F.V. (2002). Bilobalide and neuroprotection. Pharmacol. Res. 46:565-568.
8. Ding S., Dudley E., Plummer S., Tang J., Newton R.P., and Brenton A.G. (2006). Quantitative determination of major active components in Ginkgo biloba dietary supplements by liquid chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 20:2753-2760.
9. Dumont, L., C. Mardirosoff, and M.R. Tramer. (2000) Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ. 321:267-272.
10. German Federal Institute for Drugs and Medicinal Devices Commission E. (1994). Monographie:Trockenextrakt (35-67:1) aus Ginkgo-biloba-Blattern and Aceton-Wasser e.m. Bundes-Anzeiger Nr. 133.
11. Gertsch J.H., Basnyat B., Johnson E.W., Onopa J., and Holck P.S. (2004). Randomised, double blind, placebo-controlled comparison of Ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ. 328:797-102.
12. Gertsch J.H., Seto T.B., Mor J., and Onopa J. (2002). Ginkgo biloba for the prevention of severe acute mountain sickness (AMS) starting one day before rapid ascent. High Alt. Med. Biol. 3:29-37.
13. Graefe E.U., Wittig J., Mueller S., Riethling A.K., Uehleke B., Drewelow B., Pforte H., Jacobasch G., Derendorf H., and Veit M. (2001). Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol. 41:492-499.
14. Gray D., LeVanseler K., Meide P., and Waysek E.H. (2007). Evaluation of a method to determine flavonol aglycones in Ginkgo biloba dietary supplement crude materials and finished products by high-performance liquid chromatography: collaborative study. J. Aoac. Int. 90:43-53.
15. Hackett P.H., and Roach R.C. (2001). High-altitude illness. N. Engl. J. Med. 345:107-114.
16. Jowers C., Shih R., James J., Deloughery T.G., and Holden W.E. (2004). Effects of Ginkgo biloba on exhaled nasal nitric oxide during normobaric hypoxia in humans. High Alt. Med. Biol. 5:445-449.
17. Kressmann S., Biber A., Wonnemann M., Schug B., Blume H.H., and Muller W.E. (2002). Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations. J. Pharm. Pharmacol. 54:1507-1514.
18. Leadbetter G., Keyes L.E., Maaksted K.M., Olson S., Tissot van Patot M.C., and Hackett P.H. (2009). Ginkgo biloba does . . . and does not . . . prevent acute mountain sickness. Wilderness. Environ. Med. In press.
19. Liu C., Mandal R., and Li X.-F. (2005). Detection of fortification of ginkgo products using nanoelectrospray ionization mass spectrometry. Analyst. 130:325-329.
20. Liu K.-X., Wu W.-K., He W., and Liu C.-L. (2007). Ginkgo biloba extract (EGb 761) attenuates lung injury induced by intestinal ischemia/reperfusion in rats: roles of oxidative stress and nitric oxide. World J. Gastroenterol. 13:299-305.
21. Louajri A., Harraga S., Godot V., Toubin G., Kantelip J.P., and Magnin P. (2001). The effect of ginkgo biloba extract on free radical production in hypoxic rats. Biol. Pharm. Bull. 24:710-712.
22. Moraga F.A., Flores A., Serra J., Esnaola C., and Barriento C. (2007). Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollague (3696 m) in northern Chile. Wilderness Environ. Med. 18:251-257.
23. Naik S.R., Pilgaonkar V.W., and Panda V.S. (2006). Evaluation of antioxidant activity of Ginkgo biloba phytosomes in rat brain. Phytother. Res. 20:1013-1016.
24. Oyama Y., Fuchs P.A., Katayama N., and Noda K. (1994). Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons. Brain Res. 635:125-129.
25. Rimmer C.A., Howerton S.B., Sharpless K.E., Sander L.C., Long S.E., Murphy K.E., Porter B.J., Putzbach K., Rearick M.S., Wise S.A., Wood L.J., Zeisler R., Hancock D.K., Yen J.H., Betz J.M., Nguyenpho A., Yang L., Scriver C., Willie S., Sturgeon R., Schaneberg B., Nelson C., Skamarack J., Pan M., Levanseler K., Gray D., Waysek E.H., Blatter A., and Reich E. (2007). Characterization of a suite of ginkgo-containing standard reference materials. Ann. Bioanalysis Chem. 389:179-196.
26. Roach R.C., Maes D., Sandoval D., Robergs R.A., Icenogle M., Hinghofer-Szalkay H., Lium D., and Loeppky J.A. (2000). Exercise exacerbates acute mountain sickness at simulated high altitude. J. Appl. Physiol. 88:581-585.
27. Roncin J.P., Schwartz F., and D'Arbigny P. (1996). EGb 761 in control of acute mountain sickness and vascular reactivity to cold exposure. Aviat. Space Environ. Med. 67:445-452.
28. Sierpina V.S., Wollschlaeger B., and Blumenthal M. (2003). Ginkgo biloba. Am. Fam. Physician. 68:923-926.
29. Sloley B.D., Urichuk L.J., Morley P., Durkin J., Shan J.J., Pang P.K., and Coutts R.T. (2000). Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo biloba leaves. J. Pharm. Pharmacol. 52:451-459.
30. Tendi E.A., Bosetti F., Dasgupta S.F., Stella A.M.G., Drieu K., and Rapoport S.I. (2002). Ginkgo biloba extracts EGb 761 and bilobalide increase NADH dehydrogenase mRNA level and mitochondrial respiratory control ratio in PC12 cells. Neurochem. Res. 27:319-323.
31. Vogensen S.B., Stromgaard K., Shindou H., Jaracz S., Suehiro M., Ishii S., Shimizu T., and Nakanishi K. (2003). Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists. J. Med. Chem. 46:601-608.
32. World Health Organization. (1999). Folium Ginkgo biloba W.m.V.I., 1999. WHO monographs 1.